Christian Hölscher

Aβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathology

Rebecca Radde, Tristan Bolmont, Stephan A. Kaeser et al. · EMBO Reports · 2006 · 983 citations · Full text

Neurodegenerative Diseases, Robust Pathology, Degenerative Pathology +9

An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease–associated Aβ oligomers

Theresa R. Bomfim, Letícia Forny‐Germano, Luciana B. Sathler et al. · Journal of Clinical Investigation · 2012 · 812 citations · Full text

Synaptic Transmission, Synaptic Signaling, Insulin Signaling +28

The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease

Paula L. McClean, Vadivel Parthsarathy, Émilie Faivre et al. · Journal of Neuroscience · 2011 · 678 citations · Full text

Aging, Synaptic Transmission, Neurochemical Biomarkers +24

Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer’s-like pathology

Adrián Olmos‐Alonso, Sjoerd Schetters, Sarmi Sri et al. · Brain · 2016 · 532 citations · Full text

Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis

Kerry Hunter, Christian Hölscher · BMC Neuroscience · 2012 · 489 citations · Full text